ORIONS Money Stocks

[matt24d]

ERB, NICE!! article just out! Has some good info in there that I was not aware of.

-Erba Diagnostics' diverse product portfolio consists of more than 200 FDA cleared products, and more than 400 CE marked products.

-Transasia (Vazirani's first company) owns 78% of Erba, and the relationship between the two is "expected to expand Erba's customer and geographic markets."

-Transasia's customer base is expected to have access to Erba's suite of products, including its immunology platform. Transasia's customer base is five times greater than Erba's.

-Erba's geographic markets will expand into India, Eastern Europe, the Middle East, and South America. Keep in mind that Erba Manheim's Transasia division is located in India, Erba Lachema is located in Eastern Europe, and Erba DDS is located in the Middle East.

-Transasia is expected to introduce its products into Erba's sales channel.

-Erba is targeting a $60 billion in vitro diagnostics market that is growing at a rapid rate. Specifically, Erba is targeting the Infectious disease market, autoimmunity disease market, and immunoassay market with its lineup of more than 400 products.




http://seekingalpha.com/article/1921861-erba-diagnostics-this-low-float-stock-is-ready-to-fly?source=marketwatch